---
figid: PMC6717912__gr1
figlink: pmc/articles/PMC6717912/figure/fig1/
number: Figure 1
caption: Immune cell development and trafficking to the heart. Lymphoid progenitors
  traffic to the thymus, where they undergo positive and negative selection on recognition
  of new antigens or self-antigens, respectively. Positively selected T-cell clones
  migrate to the secondary lymphoid organs [lymph nodes (LNs) and spleen] and wait
  for antigen presentation by dendritic cells (DCs) to induce specific T-cell responses
  and acquisition of migratory phenotypes that will guide them to the heart. Myeloid
  progenitors traffic to secondary lymphoid organs. Heart inflammation results in
  endothelial adhesion molecules in the intramyocardial vessels that mediate T-cell
  and myeloid extravasation. Data from ischemic (solid lines) and nonischemic (dotted
  lines) models of experimental heart failure (HF) suggest that neutrophils (1) and
  monocytes (2) will be recruited from the bone marrow and the spleen by the CCR2/chemokine
  (C-C motif) ligand (CCL) 2–CCL5 pathway and contribute to heart inflammation in
  response to ischemia and pressure overload T cell (3) traffic from lymph nodes and
  use CXC chemokine receptor 3 (CXCR3) and the lymphocyte function–associated antigen
  1 (LFA-1)/intercellular adhesion molecule 1 (ICAM-1) to infiltrate the heart in
  nonischemic HF. T-cell expansion occurs in the spleen and LNs in response to ischemia,
  and LFA-1 and very late antigen 4 (VLA-4) mediate heart infiltration. CXCL, C-X-C
  motif ligand; IFN, interferon; MHC, major histocompatibility complex; PD-1, programmed
  cell death-1; PDL-1, PD-1 ligand; TCR, T-cell receptor; TNF-α, tumor necrosis factor-α;
  VCAM-1, vascular cell adhesion molecule 1.
pmcid: PMC6717912
papertitle: Heart Inflammation.
reftext: Francisco J. Carrillo-Salinas, et al. Am J Pathol. 2019 Aug;189(8):1482-1494.
pmc_ranked_result_index: '112506'
pathway_score: 0.9464406
filename: gr1.jpg
figtitle: Immune cell development and trafficking to the heart
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6717912__gr1.html
  '@type': Dataset
  description: Immune cell development and trafficking to the heart. Lymphoid progenitors
    traffic to the thymus, where they undergo positive and negative selection on recognition
    of new antigens or self-antigens, respectively. Positively selected T-cell clones
    migrate to the secondary lymphoid organs [lymph nodes (LNs) and spleen] and wait
    for antigen presentation by dendritic cells (DCs) to induce specific T-cell responses
    and acquisition of migratory phenotypes that will guide them to the heart. Myeloid
    progenitors traffic to secondary lymphoid organs. Heart inflammation results in
    endothelial adhesion molecules in the intramyocardial vessels that mediate T-cell
    and myeloid extravasation. Data from ischemic (solid lines) and nonischemic (dotted
    lines) models of experimental heart failure (HF) suggest that neutrophils (1)
    and monocytes (2) will be recruited from the bone marrow and the spleen by the
    CCR2/chemokine (C-C motif) ligand (CCL) 2–CCL5 pathway and contribute to heart
    inflammation in response to ischemia and pressure overload T cell (3) traffic
    from lymph nodes and use CXC chemokine receptor 3 (CXCR3) and the lymphocyte function–associated
    antigen 1 (LFA-1)/intercellular adhesion molecule 1 (ICAM-1) to infiltrate the
    heart in nonischemic HF. T-cell expansion occurs in the spleen and LNs in response
    to ischemia, and LFA-1 and very late antigen 4 (VLA-4) mediate heart infiltration.
    CXCL, C-X-C motif ligand; IFN, interferon; MHC, major histocompatibility complex;
    PD-1, programmed cell death-1; PDL-1, PD-1 ligand; TCR, T-cell receptor; TNF-α,
    tumor necrosis factor-α; VCAM-1, vascular cell adhesion molecule 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRA
  - TRB
  - TRD
  - TRG
  - PDCD1
  - CD274
  - CXCR3
  - ICAM1
  - CCR2
  - CCL5
  - TNF
  - IL1B
  - IL18
  - IL6
  - CXCL1
  - CXCL2
  - CXCL8
  - CXCL10
  - VCAM1
  - IFNA1
  - TCR
  - inflammation
genes:
- word: MHC/TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: MHC/TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: MHC/TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: MHC/TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: PD-1/PDL-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: PD-1/PDL-1
  symbol: PDL1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PDL-1
  symbol: PDL1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: СХCR3
  symbol: CXCR3
  source: hgnc_symbol
  hgnc_symbol: CXCR3
  entrez: '2833'
- word: ICAM-1,
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: ICAM-1,IFN-y
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: CCR2
  symbol: CCR2
  source: hgnc_symbol
  hgnc_symbol: CCR2
  entrez: '729230'
- word: CL2,CCL5,
  symbol: CCL5
  source: hgnc_symbol
  hgnc_symbol: CCL5
  entrez: '6352'
- word: CCL5,
  symbol: CCL5
  source: hgnc_symbol
  hgnc_symbol: CCL5
  entrez: '6352'
- word: TNF-a,
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-6,TNF-a,IL-1B,IL-18,
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-6,TNF-a,IL-1B,IL-18,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-6,TNF-a,IL-1B,IL-18,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6,TNF-a,IL-1B,IL-18,
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-1B,
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-18,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: CXCL1,
  symbol: CXCL1
  source: hgnc_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: CXCL2,
  symbol: CXCL2
  source: hgnc_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: CXCL8,
  symbol: CXCL8
  source: hgnc_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: CXCL1,CXCL2,CXCL8,
  symbol: CXCL1
  source: hgnc_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: CXCL1,CXCL2,CXCL8,
  symbol: CXCL8
  source: hgnc_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: CXCL1,CXCL2,CXCL8,
  symbol: CXCL2
  source: hgnc_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: СХCL10
  symbol: CXCL10
  source: hgnc_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: VCAM-1,
  symbol: VCAM1
  source: hgnc_symbol
  hgnc_symbol: VCAM1
  entrez: '7412'
- word: ICAM-1,
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: ICAM-1,VCAM-1,typeIIFN
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: CCR2
  symbol: CCR2
  source: hgnc_symbol
  hgnc_symbol: CCR2
  entrez: '729230'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
diseases:
- word: inflammation
  source: MESH
  identifier: D007249
---
